The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product, Kirkland Signature Vitamin C 1000 mg Tablet.
FDA Post-Marketing Surveillance (PMS) activities have verified that the Kirkland Signature Vitamin C 1000 mg Tablet has not gone through the registration process of the Agency and has not been issued with proper authorization in the form of Certificate of Product Registration. Thus, the Agency cannot guarantee their quality and safety.
Therefore, consumption of Kirkland Signature Vitamin C 1000 mg Tablet may pose potential danger or injury to health.
Pursuant to Republic Act No. 9711, otherwise known as the “Food and Drug Administration Act of 2009”, the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, promotion, advertising or sponsorship of health products without proper authorization from FDA is prohibited.
All concerned establishments and/or entities are warned not to distribute Kirkland Signature Vitamin C 1000 mg Tablet until it has been covered by the appropriate authorization, otherwise, regulatory actions and sanctions shall be strictly pursued.
The Food and Drug Administration (FDA) also warns the public from purchasing and consuming the following unregistered food products and food supplement:
- SHALOM HERBAL PRODUCTS Salabat Powder with Honey
- SUPER SECCO BLEND 20 in 1 Veggie-Fruit Juice
- MGR Miracle Golden Raisins
- DIAMOND ESSENTIAL PRODUCTS Green Slimming Coffee Mix
- PROSTATE CARE w/ Turmeric, Moringa & Guyabano Food Supplement Capsule
FDA issues warning vs. Kirkland Signature Vitamin C
All Local Government Units (LGUs) and Law Enforcement Agencies (LEAs) are requested to ensure that this product is not sold or made available in their localities or areas of jurisdiction.
For more information and inquiries, please e-mail us at email@example.com. To report continuous sale or distribution of unregistered health products, kindly e-mail us via firstname.lastname@example.org. You may also call the Center for Drug Regulation and Research at telephone number (02) 8809-5596. For any suspected adverse drug reaction (ADR), report immediately to FDA through this link: https://primaryreporting.who-umc.org/Reporting/ Reporter?OrganizationID=PH and fill out all the required fields.
Dissemination of the information to all concerned is requested.